Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Early Impact of the State Innovation Models Initiative on Diagnosed Diabetes Prevalence among Adults and Hospitalizations among Diagnosed Adults
  • Published Date:
    Sep 2019
  • Source:
    Med Care. 57(9):710-717
  • Language:
    English


Public Access Version Available on: September 01, 2020, 12:00 AM information icon
Please check back on the date listed above.
Details:
  • Alternative Title:
    Med Care
  • Description:
    Background:

    The State Innovation Models (SIM) Initiative invested $254 million in 6 states in Round 1 to accelerate delivery system and payment reforms.

    Objectives:

    To examine the association of early SIM implementation and diagnosed diabetes prevalence among adults and hospitalization rates among diagnosed adults.

    Research Design:

    Quasi-experimental design compares diagnosed diabetes prevalence and hospitalization rates before SIM (2010–2013) and during early implementation (2014) in 6 SIM states versus 6 comparison states. County-level, difference-in-differences regression models were estimated.

    Subjects:

    Annual average of 4.5 million adults aged 20+ diagnosed with diabetes with 1.4 million hospitalizations in 583 counties across 12 states

    Measures:

    Diagnosed diabetes prevalence among adults and hospitalization rates per 1000 diagnosed adults

    Results:

    Compared with the pre-SIM period, diagnosed diabetes prevalence increased in SIM counties by 0.65 percentage points (from 10.22% to 10.87%) versus only 0.10 percentage points (from 9.64% to 9.74%) in comparison counties, a difference-in-differences of 0.55 percentage points. The difference-in-differences regression estimates ranged from 0.49 to 0.53 percentage points (P<0.01). Regression results for ambulatory care-sensitive condition and all-cause hospitalization rates were inconsistent across models with difference-in-differences estimates ranging from −5.34 to −0.37 and from −13.16 to 0.92, respectively.

    Conclusions:

    SIM Round 1 was associated with higher diagnosed diabetes prevalence among adults after a year of implementation, likely because of SIM’s emphasis on detection and care management. SIM was not associated with lower hospitalization rates among adults diagnosed with diabetes, but SIM’s long-term impact on hospitalizations should be assessed.

  • Pubmed ID:
    31295167
  • Pubmed Central ID:
    PMC6690748
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: